ETF · PBE
Invesco Biotechnology & Genome ETF
Closing price No closing price on file for PBE.
About this page
PBE is a fund, not a company
An ETF has no officers or directors who report trades on Form 4, and no quarterly earnings. So this page shows the funds that hold it (from their 13F reports) and any trades members of Congress reported in it.
Who owns it
123 funds report owning PBE, up from 107
New29
Added24
Held53
Trimmed17
Sold out13
Last quarter
Who bought and who sold
Change in shares held from Jun 30 to Sep 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.
Top holders
Biggest funds in PBE
| Fund | Value | Change |
|---|---|---|
| Morgan Stanley | $40.8M | +183% |
| HighTower Advisors, LLC | $40.3M | 61x |
| Bank of America Corp | $11.5M | +107% |
| Royal Bank of Canada | $10.3M | +110% |
| United Capital Financial Advisors, LLC | $10M | −1% |
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.